You're reading the free version. Trader adds the live tape and alerts.
Start tracking
CTNM Sale Disclosure
Stengone Carmine N. · SEC Form 4 · Filed Sep 8, 2026
Sale
Calculated transaction value
$41.14K
Stengone Carmine N. CEO And President
CTNM
Transaction date
Sep 8, 2026
Public filing date
Sep 8, 2026
Filing lag
Filed same day
CTNM daily price context
Close on/before transaction
$15.94
Sep 8, 2026
First close after public filing
$15.14
Sep 9, 2026
30-day return after filing
-12.95%
Through Oct 8, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Class A Common Stock
- Quantity / price
- 2,500 shares @ $16.46
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001628280-26-060962
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$43.67K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Contineum Therapeutics, Inc. CTNM | Exercise | Sep 8, 2026 | $2.52K |
| Contineum Therapeutics, Inc. CTNM Current | Sale | Sep 8, 2026 | $41.14K |
| Contineum Therapeutics, Inc. CTNM | Exercise | Sep 8, 2026 | $0 |